Efficacy of infiltration of chlorhydrate of ropivacaine in the prevention of chronic breast pain after surgery for breast cancer.

Trial Profile

Efficacy of infiltration of chlorhydrate of ropivacaine in the prevention of chronic breast pain after surgery for breast cancer.

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Aug 2016

At a glance

  • Drugs Ropivacaine (Primary)
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 May 2012 Actual patient number is 260 according to ClinicalTrials.gov.
    • 14 May 2012 Actual end date (Nov 2008) added as reported by ClinicalTrials.gov.
    • 14 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top